CD4 and cancer: Previous studies have shown that the expression of PD-L1 in TIICs was positively correlated with the number of CD4+ T lymphocytes and CD8+ T lymphocytes [38], and a high level of expression of CD4+ and CD8+ T cells has been correlated with better cancer survival [36, 39].